|
Volumn 19, Issue 6, 2009, Pages 629-637
|
Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
RNA;
TETRAZOLIUM;
THIAZOLE DERIVATIVE;
THIAZOLYL BLUE;
THYROTROPIN;
ARTICLE;
BIOSYNTHESIS;
CELL CYCLE S PHASE;
CELL DIFFERENTIATION;
CELL MOTION;
CELL SURVIVAL;
CONFOCAL MICROSCOPY;
DOWN REGULATION;
DRUG EFFECT;
DRUG RESISTANCE;
GENETICS;
HUMAN;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PHENOTYPE;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
THYROID TUMOR;
TUMOR CELL LINE;
WESTERN BLOTTING;
ANTINEOPLASTIC AGENTS;
BLOTTING, WESTERN;
CELL DIFFERENTIATION;
CELL LINE, TUMOR;
CELL MOVEMENT;
CELL SURVIVAL;
DOWN-REGULATION;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MICROSCOPY, CONFOCAL;
NEOVASCULARIZATION, PATHOLOGIC;
PHENOTYPE;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RNA, NEOPLASM;
S PHASE;
SIGNAL TRANSDUCTION;
TETRAZOLIUM SALTS;
THIAZOLES;
THYROID NEOPLASMS;
THYROTROPIN;
|
EID: 68849124969
PISSN: None
EISSN: 15579077
Source Type: Journal
DOI: 10.1089/thy.2008.0355 Document Type: Article |
Times cited : (12)
|
References (0)
|